Association of 5,10-Methylenetetrahydrofolate Reductase Polymorphisms, Arsenic Metabolism, and Arsenic Skin Lesions in Residents Chronically Exposed to Arsenic in Drinking Water

Furong Deng,Xinbiao Guo
DOI: https://doi.org/10.1097/01.ede.0000392083.21279.b7
2011-01-01
Epidemiology
Abstract:PP-31-168 Background/Aims: This study was conducted to investigate the relationship between 5,10-methylenetetrahydrofolate reductase (MTHFR) genetic polymorphism, arsenic metabolism, and arsenic skin lesions in residents chronically exposed to arsenic in drinking water (≥0.05 mg/L). Methods: In all, 50 subjects with skin lesions and 35 subjects without skin lesions recruited from an endemic arsenic poisoning area of Shanxi Province, China. Urinary inorganic and methylated arsenic was specified by high performance liquid chromatography combined with hydride generation atomic fluorescence spectrometry. MTHFRC677 polymorphism was determined by polymerase chain reaction-restriction fragment length polymorphism. Micronuclei assay was conducted to evaluate the genetic toxicity of arsenic. Results: The frequencies of TT genotype and T allele in case group were 34.0% and 56.0%, respectively, and were not significantly different from those in the controls (34.3% and 52.9%). MTHFR 677 polymorphism was significantly associated with arsenic methylation. Subjects with the genotype of CT/TT had the increased percentage of urinary As3+ (P = 0.029) and decreased percentage of urinary dimethylarsinic acid (P = 0.033). No associations were observed between arsenic methylation capacity and skin lesions or micronuclei frequency. Conclusion: MTHFRC677 polymorphism was significantly associated with arsenic methylation. We did not find the associations between genetic polymorphism of MTHFR(677C-T) and skin lesions or micronuclei frequency.
What problem does this paper attempt to address?